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Abstract
Assessment of the effectiveness of tuberculosis controlBackground: 
strategies requires the periodic measurement of M. tuberculosis 
transmission in populations, which is notoriously difficult. One
well-established method is to measure the prevalence of infectious
pulmonary tuberculosis in the population which is then repeated at a
second time point after a period of ‘intervention’, such as scale up of the
Search-Treat-Prevent strategy of the Zero TB Cities initiative, allowing for a
‘before and after’ comparison. 
The concurrent adult pulmonary tuberculosis prevalence surveyProtocol: 
(using digital radiography and Xpert MTB/RIF Ultra) and child M.
infection survey (using QuantiFERON-TB® Gold Plus) willtuberculosis 
primarily provide a baseline measure of the burden of adult infectious
tuberculosis in Karachi and assess whether a large-scale interferon gamma
release assay survey in children aged 2 to 4 years is feasible. The target
population for the prevalence survey is comprised of a stratified random
sample of all adults aged 15 years and above and all children aged 2 to 4
1-3 1 2 1
4 4 5 4
1 4 1,4 6 6
7 3,8 8 9
4,5
1
2
3
4
5
6
7
8
9
 Reviewer Status AWAITING PEER REVIEW
 06 Jul 2020,  :159 First published: 5
https://doi.org/10.12688/wellcomeopenres.15963.1
 06 Jul 2020,  :159 Latest published: 5
https://doi.org/10.12688/wellcomeopenres.15963.1
v1
Page 1 of 14
Wellcome Open Research 2020, 5:159 Last updated: 06 JUL 2020
 sample of all adults aged 15 years and above and all children aged 2 to 4
years resident in four districts in Karachi. The survey procedures and
analyses to estimate pulmonary tuberculosis prevalence are based on the
World Health Organization methodology for tuberculosis prevalence
surveys.
The study protocol has been approved by theEthics and dissemination: 
Interactive Research Development / The Indus Hospital Research Centre
Research Ethics Committee in Karachi, Pakistan and the London School of
Hygiene & Tropical Medicine Research Ethics Committee. Due to
non-representative sampling in this setting, where a large proportion of the
population are illiterate and are reluctant to provide fingerprints due to
concerns about personal security, verbal informed consent will be obtained
from each eligible participant or guardian. Results will be submitted to
international peer-reviewed journals, presented at international conferences
and shared with participating communities and with the Provincial and
National TB programme.
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Introduction
Current strategies are failing to contain the global tuberculosis 
epidemic, and are far from achieving the sustained reductions 
in tuberculosis disease incidence of up to 17% per year which 
are required to meet the targets set out in the World Health 
Organization (WHO) End TB Strategy by 20351. A paradigm 
shift in global tuberculosis control strategy is needed in order 
to break the Mycobacterium tuberculosis (M. tuberculosis) 
transmission cycle and make real progress in ending the 
epidemic.
The Zero TB Cities Initiative is one such approach which 
endorses the implementation of integrated evidence-based inter-
ventions at the community-level. The aim of the initiative is 
to create “islands of tuberculosis elimination” through (i) active 
case-finding (ACF) using systematic and evidence-based diag-
nostic algorithms (‘search’), (ii) early and effective treatment 
(‘treat’) and (iii) a reduction in M. tuberculosis exposure 
through infection prevention and control in healthcare facili-
ties including ultraviolet germicidal irradiation and provision of 
preventive therapy for high risk groups (‘prevent’)2. This 
‘Search-Treat-Prevent’ strategy has been adopted by key stake-
holders including the Stop TB Partnership and a number of 
non-governmental organisations - Partners in Health, Advance 
Access & Delivery, Interactive Research and Development 
(IRD), underpinned by academic input from the Centre for 
Global Health Delivery-Dubai, Harvard Medical School, 
in a number of cities, namely Chennai, Lima and Karachi3. 
However the effectiveness of this comprehensive ‘Search-Treat-
Prevent’ approach in reducing M. tuberculosis transmission 
at a population-level in large, urban high tuberculosis burden 
settings in the 21st century is unclear.
Assessment of the effectiveness of such tuberculosis control 
strategies requires the periodic measurement of M. tuberculo-
sis transmission in populations, which is notoriously difficult 
and relies on proxy measures, assumptions and combination 
approaches4. One well-established method is to measure the 
prevalence of infectious pulmonary tuberculosis in the popula-
tion, which provides an estimate of the burden of diagnosed and 
undiagnosed culture-confirmed tuberculosis in a population 
at a given time. The prevalence survey can then be repeated 
at a second time point after a period of ‘intervention’, such as 
scale up of the Search-Treat-Prevent strategy, allowing for a 
‘before and after’ comparison. However, a reduction in the prev-
alence of adult pulmonary tuberculosis may occur because of 
several reasons, such as a reduction in M. tuberculosis trans-
mission or in a reduction in progression from infection to 
disease or a reduction in disease duration or even because of 
secular trends, e.g. improvement in socio-economic conditions 
or mass in- or out-migration. In addition, in settings where the 
majority of current active disease is the result of reactivation 
from historic transmission, M. tuberculosis transmission may 
show a decrease with minimal reduction in prevalence. Inter-
pretation of any changes in adult pulmonary disease prevalence 
will therefore be aided by simultaneously undertaking a survey 
which measures another parameter of M. tuberculosis transmis-
sion at a population-level, such as risk of M. tuberculosis infec-
tion5. Accurately determining the prevalence of M. tuberculosis 
infection in a population allows derivation of an average 
annual risk of M. tuberculosis infection risk (ARTI), under 
the assumption of no change in risk over calendar time. 
ARTI therefore reflects cumulative lifetime infection risk and 
measures the force of infection with amount of delay deter-
mined by the age group in which the M. tuberculosis infection 
prevalence survey is conducted. Acknowledging the differ-
ences in transmission dynamics between adults and children, 
choosing younger age groups has the advantage of calculated 
ARTI being bracketed within a relatively narrow period 
between the average birth date of the group and the date of the 
survey6. Interferon gamma release assays (IGRAs) are one 
way of inferring infection status and have a higher specificity 
compared to tuberculin skin tests (TST), especially in young 
recently BCG-vaccinated children7. However, these diagnos-
tic tests have not been implemented at scale in children aged 
under five years in high-burden resource-limited settings.
Study rationale
The rationale for this concurrent adult pulmonary tuberculo-
sis prevalence survey and child IGRA survey in Karachi is 
to primarily provide a baseline measure of the burden of 
infectious tuberculosis (culture-confirmed adult pulmonary tuber-
culosis) in 2018 to 2019 (at the start of fully scaled up imple-
mentation of the Zero TB Karachi initiative) and to see if a 
large-scale IGRA survey in children aged 2 to 4 years is fea-
sible. An IGRA survey in children aged 2–4 years, if feasible 
would provide an estimate of the ARTI over the last three years. 
In brief, the Zero TB Karachi initiative involves ACF using 
mobile digital radiography interpreted by computer-aided detec-
tion of tuberculosis software, CAD4TB™ (Diagnostic Image 
Analysis Group, Radboud University Medical Center, Nijmegen, 
the Netherlands) and sputum examination using Xpert MTB/RIF 
(Cepheid, Sunnyvale, CA, USA); post-exposure treatment of 
household contacts of index patients with drug-sensitive tubercu-
losis; ultraviolet germicidal irradiation (UVGI) light installation 
in high-volume outpatient departments and pulmonary medicine 
wards; strengthening of screening and management of childhood 
tuberculosis; and integrated case-based data capture using an 
Android application linked to the OpenMRS platform across the 
whole of the city.
The aim is to assess whether a reduction in person-to-person 
M. tuberculosis transmission has occurred as result of the 
Zero TB interventions in Karachi. The adult tuberculosis preva-
lence and child IGRA survey described here will serve as the 
baseline measure and will be repeated in four years’ time (an 
end line survey in 2022–2023) using the same methodology as 
described here with the aim to conduct a before-and-after 
comparison.
Study objectives
The primary objective of this study is to estimate the period 
prevalence of culture-confirmed (diagnosed and undiagnosed) 
adult pulmonary tuberculosis in Karachi in 2018 to 2019.
The secondary objectives are to assess the feasibility of conduct-
ing a large-scale IGRA survey in young children and estimate 
the ARTI in children aged 2 to 4 years in Karachi. If the child 
IGRA survey is feasible then the plan would be to repeat the 
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IGRA survey as part of the end line survey in 2022–2023 in 
children aged 2 to 8 years stratified by those born after the 
implementation of Zero TB (children aged 2 to 4 years) and 
those born before/during early implementation of the Zero TB 
initiative (children aged 5 to 8 years).
Study outcomes and process measures
1.   Adult tuberculosis prevalence survey:
Primary outcome
i.    Prevalence of all culture-confirmed pulmonary tuber-
culosis including those individuals already diagnosed 
and on treatment
2.    Child M. tuberculosis infection survey and IGRA 
feasibility study:
Secondary outcomes
i.     Feasibility-related:
a.    proportion of eligible children who were 
enrolled of total eligible population 
(participation)
b.    proportion of valid IGRA results obtained
ii.     ARTI based on the prevalence of M. tuberculosis 
infection in children aged 2–4 years
Process measures
1.    Adult pulmonary tuberculosis prevalence survey:
i.      Proportion of eligible participants screened with 
symptom screen and chest x-ray (CXR)
ii.     Proportion of participants eligible for sputum 
collection who submitted sputum
iii.    Proportion of sputum samples contaminated
2.    M. tuberculosis infection prevalence survey in young 
children and IGRA feasibility study:
•    Proportion of eligible participants with successful 
venepuncture
•    .Proportion of samples in the laboratory within 
16 hours of blood draw
•    .Proportion of indeterminate IGRA tests
Methods
Study design
A cross-sectional study of infectious (bacteriologically con-
firmed diagnosed and undiagnosed) adult pulmonary tuberculosis 
using digital radiography and Xpert MTB/RIF Ultra (Cepheid, 
Sunnyvale, CA, USA) and a cross-sectional study of M. tuber-
culosis infection using QuantiFERON-TB® Gold Plus (Qiagen, 
Germantown, USA) in young children will be undertaken in 
Karachi, the provincial capital of Sindh province. 
Study period and setting
Recruitment began in March 2018 and will continue until the 
target sample size has been achieved. 
Due to logistical constraints, namely travel time and lim-
ited resources, the survey will be restricted to four districts of 
Karachi (Korangi, Karachi Central, Karachi South and parts 
of Karachi West). These districts include approximately 65% 
of the total 14.9 million population of Karachi as per the 
2017 census8. All included districts are each made up of a com-
bination of formal and informal settlements (slums) known 
locally as katchi abadis. The survey covers both the formal and 
informal settlements to ensure a representative sample. Several 
cantonment areas which serve as military, air force and naval 
bases with associated residential areas are excluded as access 
to these areas are restricted and require special clearance to 
enter.
Prior to the Zero TB Karachi initiative, the Indus Hospital, 
a free-of-charge healthcare facility located in Korangi district, 
in collaboration with Interactive Research and Development 
(IRD), a not-for-profit organisation, received several grants to 
increase tuberculosis patient notifications from the private sec-
tor over the period of 2010–2015 as part of the TB REACH 
initiative of the Stop TB Partnership and the Unitaid-funded 
TBXpert project. Korangi district was the designated focus for 
implementation of these TB grants as the population in this 
area was identified as one of the most disadvantaged in Karachi 
with poor access to healthcare. The first of these grants funded 
an extensive ACF campaign in 2011 in Korangi district, which 
resulted in a doubling of tuberculosis notification rates in this 
part of Karachi compared to an adjacent control area9. Varying 
intensity of ACF has continued in this district since 2011 and 
the resulting infrastructure and social community mobilisation 
from these grants, including the Xpert MTB/RIF scale-up in the 
city in 2013–2014 continues to impact on tuberculosis case- 
finding. Figure 1 below illustrates the timeline of the imple-
mentation of tuberculosis control interventions from 2008 to 
2024.
Participants
The target population for the prevalence survey is comprised 
of a stratified random sample of all adults (males and females 
including pregnant women) aged 15 years and above, resi-
dent in the four districts, and the target population for the IGRA 
survey includes a stratified random sample of all resident 
children aged 2 to 4 years in the same four districts.
Inclusion criteria: Household members, defined as those who 
have slept in the household the night before the start of enu-
meration in the selected neighbourhood block are eligible for 
inclusion in the survey.
Exclusion criteria: Individuals who are resident in public and 
private institutions which require special clearance (prison, 
military/air force/naval, diplomatic compounds, schools, hotels, 
refugee camps and health facilities) are excluded.
Study sample size calculation
Adult pulmonary tuberculosis prevalence survey. A nationwide 
cross-sectional prevalence survey of adult pulmonary 
tuberculosis was conducted in Pakistan in 2010–2011 which 
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Figure 1. Timeline of tuberculosis control interventions by geographical area.
found prevalence estimates for smear and culture confirmed 
tuberculosis of 282 per 100,000 population ((95% confi-
dence interval (CI) 161–402 per 100,000) and 363 per 100,000 
population (95% CI 229 - 497 per 100,000), respectively), in 
Sindh province10. Assuming a higher prevalence of culture con-
firmed tuberculosis in the megacity of Karachi compared to the 
provincial estimate, an estimate of 400 per 100,000 population of 
culture confirmed pulmonary TB cases was used for the sam-
ple size calculation. Thus a target sample of 21,668 enumerated 
adults will provide a relative precision of 25% assuming a 
design effect of 1.128 (D=1 + mk2µ11, where m= 200 [number of 
individuals per cluster], k=0.4 [coefficient of variation] and 
µ=0.004 [prevalence estimate]), and an expected participation 
rate of 75%.
However, to detect a reduction in tuberculosis prevalence in a 
follow-up survey ideally to take place in 4–5 years’ time and 
assess whether Zero TB Karachi initiative has had an impact 
on transmission, the sample size will have to be substantially 
larger. To have at least 80% power to detect a 33% reduction in 
tuberculosis prevalence in the follow-up survey (compared to 
the baseline survey) with a minimum participation rate of 75% 
in each survey, a sample of at least 43,734 at baseline and a simi-
lar sample size in 4 years’ time would be required. Therefore, 
our overall target sample size for this survey is 44,000.
M. tuberculosis infection prevalence survey in young children 
(2- to 4-year-olds). We did not conduct a formal sample size 
calculation for the child M. tuberculosis infection prevalence 
survey as the primary objective is to assess feasibility of 
undertaking a large-scale community IGRA survey in this 
population. 
Sampling method
Rationale for sampling design with oversampling of Korangi 
district: We hypothesise that the prevalence of adult culture- 
confirmed pulmonary tuberculosis may be lower in Korangi 
district, despite being one of the most poverty-stricken districts, 
due to the longer-term ACF efforts implemented in the district 
(see Figure 1). Although the aim of this study is not to assess 
a difference in the burden of disease across different parts of 
Karachi, it is important to quantify (albeit crudely) any differ-
ences in the prevalence of adult tuberculosis and M. tuberculosis 
infection in children at baseline of the Zero TB Karachi 
Initiative across districts. Without these data, interpretation of 
findings from the follow-up survey assessing the impact of the 
Zero TB Karachi Initiative in 4–5 years’ time will be difficult.
Sampling approach: A cluster sampling method for the sur-
vey has been employed, with the a priori plan to oversample 
Korangi district due to the potentially lower prevalence of adult 
culture-confirmed pulmonary tuberculosis (see above). For 
ease of description of the sampling method, we define Korangi 
district as the ‘prior ACF’ zone and Karachi South, Central 
and West districts as the ‘no prior ACF’ zone. A total of 44,000 
adults will be invited to participate in the study stratified by 
zone: 22,000 individuals from Korangi district (‘prior ACF’ zone) 
and 22,000 individuals from the ‘no prior ACF’ zone (Karachi 
South, Karachi Central and Karachi West districts). This same 
stratified sampling strategy by zone will be employed in the 
end line survey in 2022–2023. Table 1 shows how the 
study population is stratified by district and the number of 
neighbourhood blocks to be sampled per district.
Each district is made up of administrative units called ‘tehsils’ 
(subdivisions). We calculated the number of neighbourhood 
blocks per tehsil to be sampled in each district based on the 
adult population size of each tehsil as per the 2017 Census of 
Pakistan8. Some of the tehsils in Karachi South are predominantly 
commercial areas and are inaccessible to mobile x-ray vans, 
as found during a pilot run in 2017 and so have been excluded 
from the sampling frame. In addition, we will only sample 
those tehsils in Karachi West which border Karachi Central and 
Karachi South for the logistical reason of keeping the transport 
time of the mobile x-ray vans to under 4 hours per day.
Data provided by the Sindh Katchi Abadi Authority have been 
used to estimate the proportion of the population residing in 
katchi abadi (informal settlements) within each district 
(ranging from 8 to 18%). These data will guide the selection 
of neighbourhood blocks from katchi abadis to be consistent 
with the overall proportion of the population residing in katchi 
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Table 1. Target screening population and number of neighbourhood blocks to be surveyed stratified by 
prior ACF zone and No prior ACF areas.
Prior ACF 
zone
No prior ACF 
zone
Korangi 
district
Karachi 
South district
Karachi 
Central district
Karachi 
West district
Adult population (million)1 1.7 1.3 2.1 2.7
Percentage of adult population residing in 
the katchi abadis at district level2
8 10 18 8
Number of tehsil selected / total number of 
tehsil per district (%)
4/4 (100) 4/7 (57) * 5/5 (100) 4/8 (50) **
Target adult population for TB prevalence 
survey screening
22,000 6,000 9,500 6,500
Percentage of total adult population to be 
sampled per district (%)
1.3 0.5 0.5 0.2
Total number of neighbourhood blocks to 
be surveyed3
110 30 48 33
Number of neighbourhood blocks defined 
as katchi abadis to be sampled
9 3 9 3
1 Estimated adult population calculated using total population of district as per Pakistan Bureau of Statistics 2017 census data 
multiplied by 0.7 based on demographic structure of Pakistan that 70% of population is ≥15 years (Data sources: Pakistan 
Bureau of Statistics http://www.pbs.gov.pk/content/block-wise-provisional-summary-results-6th-population-housing-census-
2017-january-03-2018 and CIA.gov: https://www.cia.gov/library/publications/resources/the-world-factbook/geos/pk.html)
2 Data provided by the Sindh Katchi Abadi Authority (unpublished)
3 Assuming an average of 200 adults per block
* Several tehsils in Karachi South were found to be highly commercial areas and inaccessible to mobile vans during a pilot run 
of operations in 2017 so were excluded from the sampling frame
** Includes only those tehsils of Karachi West which border Karachi Central and Karachi South for logistical reasons (transport 
time of mobile x-ray vans from headquarters of ≤ 2 hours)
katchi abadis informal settlements; tehsils administrative unit of a district
abadis at the district level. For example, of the 110 neigh-
bourhood blocks in Korangi district, 9 neighbourhood blocks 
will be selected from areas defined as katchi abadis, and the 
remaining 101 neighbourhood blocks will be selected from 
other areas to reflect the 8% of the population of that district 
which live in katchi abadis. 
Selection of neighbourhood blocks: ArcGIS® software 
(Environmental Systems Research Institute (ESRI), Release 10.5, 
Redlands, CA) is used to select random points within subdivi-
sions of districts using the Select Random Points function. The 
random locations are then overlaid on the satellite imagery 
available through ArcGIS®. If the point lies in a non-residential 
area it is excluded and the next point in the list is used. If the 
point is thought to lie in a residential area, a neighbourhood 
block (based on geographically adjacent households with 
approximately 200 individuals aged ≥ 15 years) is manually 
drawn on the map with the aim of keeping the random point in 
the middle of the block. The neighbourhood block is constructed 
using our prior experience of population sizes of differing 
blocks based on a qualitative assessment of the satellite imagery 
of the building structures in Karachi (for example, larger area 
outlined for areas where residential buildings are more spaced 
and smaller blocks for buildings closer together – see Figure 2). 
The random points, and outline of the block are then con-
verted into KML format (file format used to display geographic 
data in Google Earth) and sent to the field teams, who 
can access them on smartphones to navigate to their defined 
blocks. Figure 3 shows the distribution of neighbourhood blocks 
sampled across the four districts of Karachi. 
Study procedures
Adult pulmonary tuberculosis prevalence survey. The pro-
cedures are based on the WHO methodology for tuberculosis 
prevalence surveys12.
Community sensitisation and enumeration
In brief, field workers conduct community sensitisation and 
enumeration of households with door-to-door census in each 
randomly selected neighbourhood block during weekdays 
(Monday to Thursday). If the neighbourhood block is non- 
residential or access is restricted for security reasons, e.g. naval 
or army residential areas and/or self-appointed community 
leaders (e.g. imam of the local mosque or community elders) 
do not endorse the survey, the block is deemed non-eligible. 
In that case the team moves into the next randomly selected 
block on the list and the reason for non-eligibility of the 
previous block is logged.
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Figure 2. Satellite imagery of various parts of Karachi. Red dot depicts the random point. (A) A residential area – with relevant organised 
layout. (B) A block within a katchi abadi where buildings are more haphazardly spaced. (C) An industrial area which would be excluded, and 
another random point selected.
At the start of the community sensitisation, a local community 
head is identified and asked to lead community mobilisation 
and assist in the completion of a short socio-economic ques-
tionnaire at the neighbourhood block-level, including details 
on access to local healthcare facilities, schools, and water 
source. Table 2 outlines the definition of the survey terms used 
during enumeration.
Enumeration of the households within a neighbourhood block 
starts with identification of all residential buildings in the block 
with the exclusion of empty plots, commercial buildings and 
schools. The team leader assigns a starting point of the 
block before enumeration begins. This is usually the building on 
the edge of the neighbourhood block closest to the main road. 
The team then move from residential building to the next near-
est residential building, enumerating the households until a 
target of 200 adults per neighbourhood block is reached. 
Field procedures
There are six field teams and each field team consisted of one 
team leader, two female counsellors and three male field 
workers during the week and then an additional mobile x-ray van 
driver, radiographer and phlebotomist at the weekends (Friday/ 
Saturday/Sunday). Screening takes place at the weekend to max-
imise the chances of finding individuals in their homes, espe-
cially males. Households are visited a maximum of three times 
on different days (Friday/Saturday/Sunday) aiming to interview 
all adult household members and reduce the numbers of 
eligible participants being “missed”.
Eligible individuals (aged ≥ 15 years) who have given informed 
verbal consent undergo a questionnaire including information 
on previous and current tuberculosis treatment, tuberculosis 
symptoms (cough, haemoptysis, fever, night sweats and weight 
loss), history of smoking and diabetes. They are all referred 
to the x-ray van stationed in the neighbourhood for a digital 
CXR. A computer-aided software for reading radiological 
signs of tuberculosis, CAD4TB™ (Diagnostic Image Analysis 
Group, Radboud University Medical Center, Nijmegen, the 
Netherlands) is used to evaluate CXRs in this survey. The 
software identifies shape and textural abnormalities in chest 
x-ray images to produce an abnormality score ranging from 
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Figure 3. Map of Karachi showing distribution of neighbourhood blocks to be sampled by districts. *The central area between Karachi 
Central, Korangi and Karachi South has not been sampled as this is where the most densely commercial areas are located and also the army 
and naval cantonments.
Table 2. Definitions of survey terms.
Survey term Definition
Neighbourhood block A geographically localized community defined by the randomly selected point which is 
then outlined on the designated map (cluster size of approximately 200 adults)
Residential building A building including a house, unit or flat where people live and sleep
Household Basic residential unit defined by all members who share the main meal (usually evening)
Resident Any person who has slept in the household the night before the start of enumeration 
0 (normal) to 100 (highly abnormal)13. A cut off CAD4TB 
score of 65 is used in the survey to identify an ‘abnormal’ 
CXR based on analysis of local programmatic data examining 
the association of CAD4TB score and prevalence of 
Xpert-positivity14.
If either the tuberculosis symptom screen is positive (cough 
duration ≥ 2 weeks and/or fever and/or weight loss and/or 
night sweats and/or haemoptysis) or CAD4TB score ≥ 65, indi-
viduals are asked to submit two sputum samples, an instructed 
spot sputum sample on the same day and an early morning spu-
tum. Individuals who are already on tuberculosis treatment at 
the time of screening are asked to submit two (on the spot and 
early morning) sputum samples, irrespective of symptom screen 
and digital CXR. Individuals with physical disabilities that 
prevent them from being able to mobilise from their home to 
the mobile x-ray van and pregnant women undergo a symptom 
screen only and are asked to submit two sputum samples irre-
spective of symptoms. Contact numbers of all individuals who 
submit a sputum sample are recorded. If the Xpert MTB/RIF 
Ultra (Cepheid, Sunnyvale, CA, USA) result is ‘trace’-positive, 
an additional sample (third sample) is collected, if possible, 
for repeat Xpert MTB/RIF Ultra testing. All sputum samples 
are collected by the field workers and transported to the Indus 
Hospital central laboratory for processing.
All study participants who are Xpert MTB/RIF Ultra posi-
tive including ‘trace positive’ on any samples are referred to 
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the nearest health facility for clinical review and to start tuber-
culosis treatment if appropriate. We plan to contact all partici-
pants who are referred for either tuberculosis treatment or further 
clinical review within one month of referral to ascertain 
outcome, e.g. start of tuberculosis treatment or need for further 
clinical observation etc. Study participants found to have res-
piratory symptoms, such as chronic cough or difficulty breath-
ing are also referred to attend the nearest health facility for 
further examination irrespective of Xpert MTB/RIF Ultra test.
Child M. tuberculosis infection survey
Children aged 2 to 4 years old are recruited from the same 
households as the adult participants for the tuberculosis preva-
lence survey. Guardians of children aged 2 to 4 years old are 
asked for informed verbal consent (see Ethics section below), 
and complete a brief verbal questionnaire including a symptom 
screen (cough, fever, weight loss, failure to thrive and decreased 
playfulness), history of tuberculosis treatment, and history 
of any tuberculosis contact within last two years. 
A phlebotomist trained in paediatric venepuncture collects 4ml 
of blood from all children whose guardians’ consent to blood 
collection for QuantiFERON-TB® Gold Plus (QFT®-Plus) 
according to manufacturer’s instructions. Blood samples are 
transported to the Indus Hospital central laboratory in Korangi 
within 6 hours of venepuncture. Children with positive QFT 
results are referred to the closest of one of three hospitals, which 
provide specialist childhood tuberculosis care, where the child 
is assessed and evaluated for tuberculosis, including a full diag-
nostic work-up by a trained paediatrician. Once tuberculosis 
has been excluded, children are started on isoniazid preven-
tive therapy and followed-up for duration of treatment by the 
childhood tuberculosis programme.
Figure 4 summarises the study procedures for the adult and 
child surveys.
Laboratory procedures
Adult pulmonary tuberculosis prevalence survey
Sputum samples transported in cooler boxes on the day the 
samples are submitted and are decontaminated using the stand-
ard NAOH-NALC method (final NAOH concentration 1% pre-
pared inhouse). The pellet is re-suspended in 1.5 ml of normal 
saline. 0.8 ml, 0.5ml and 0.2ml of the suspension of early morn-
ing samples or on-spot samples (if no early morning sample 
collected) are tested using Xpert MTB/RIF Ultra, liquid culture 
(BACTEC™ Mycobacterial Growth Indicator Tube (MGIT™) 
960 [BD])) and solid media (Lowenstein Jensen (LJ) [BD]) 
respectively. If both an on-spot and early morning sample is 
available, the early morning sample is inoculated in liquid and 
solid culture only. Cultures are incubated at 37°C in the 
automated MGIT960 and standard incubator system for a maxi-
mum of 42 and 56 days. Growth is identified by immune chro-
matographic identification test (Standard Diagnostics, Korea) 
for M. tuberculosis.
Laboratory cross-contamination is investigated as per local 
laboratory standard operating protocol in the event where two 
samples processed on the same day grow M. tuberculosis or 
when a single culture-positive sputum result (Xpert Ultra- 
negative and culture-negative on the other sample) is obtained 
for a study participant.
Child M. tuberculosis infection survey
The blood samples are incubated at 37 ± 1°C for 16–24 hours 
in the Indus Laboratory within 16 hours after collection. After 
incubation, the tubes are centrifuged for 15 minutes at 
2000–3000 x g and the plasma harvested. The standard QFT 
Plus® enzyme-linked immunosorbent assay (ELISA) kit is used. 
Samples from 22 subjects are analysed on a single plate in each 
run of ELISA. The optical density of each well is measured 
on a plate reader (Diatek DR-200 Bs microplate reader) using 
the QFT-Plus analysis software (Ascent Software Version 2.6, 
Thermo Scientific). The concentration of released interferon-
gamma (IFN-γ) in each tube is calculated by subtracting the value 
of the nil (negative control) tube. If the coefficient of variation 
for the result is less than 15% and the correlation coefficient 
for the standard curve is greater than 0.98, the assay is techni-
cally valid. All the results are interpreted by referring to a 4-point 
standard curve as per the manufacturer’s instructions.
Case definitions
1.    Adult pulmonary tuberculosis prevalence survey:
 Definite bacteriologically confirmed pulmonary tuber-
culosis case is defined as study participant with one culture- 
positive sputum specimen and at least one of the following 
conditions:
•   Xpert Ultra-positive
•    .Culture-positive (either LJ or MGIT) in another 
specimen
Probable bacteriologically confirmed pulmonary tuber-
culosis case is defined as a study participant with an Xpert 
Ultra-positive sputum specimen but culture-negative on one or 
both sputum samples or a study participant with a single cul-
ture-positive sputum where laboratory cross-contamination 
has been excluded.
These definitions deviate from the case definitions recom-
mended by the WHO Global Task Force on TB impact 
measurement for tuberculosis prevalence surveys15. Firstly 
smear-status has not been included as part of the case defini-
tion as smear-microscopy has been replaced by use of Xpert 
Ultra in this setting. Abnormal CXRs are also not includ-
ed as part of the case definition as only computer-assisted 
detection of lung abnormalities are undertaken as part of the 
survey as a triage tool for sputum submission. Due to bud-
get limitations, there is no central audited reading of CXRs 
by a trained radiologist and therefore CXRs are only used to 
identify individuals eligible for sputum submission rather 
than as a diagnostic modality of pulmonary tuberculosis. 
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Figure 4. Flowchart of study procedures.
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If a participant has no symptoms and the CAD4TB 
score <65 then Xpert Ultra and culture results were 
assumed to be negative. 
2.   Child M.tuberculosis infection survey:
M. tuberculosis infection is defined as having a posi-
tive QuantiFERON®-TB Gold Plus (QFT®-Plus) assay. A 
QFT®-Plus assay is considered positive, as per the definition 
recommended by the manufacturer, if either TB Antigen tube 
interferon-gamma (IFN-γ) response is significantly above 
the Nil IFN-γ value (≥0.35 IU/ml and ≥25% of the Nil 
IFN-γ value). For the test to be valid, the positive control 
(Mitogen) minus the Nil IFN-γ value must be ≥0.5 IU/ml 
and the Nil IFN-γ/ml value must be ≤ 8.0 IU/ml.
Data collection and sources
The data collection tool is a custom-built application using an 
Android tablet linked to the OpenMRS platform.
The application includes: (i) an enumeration form at the 
neighbourhood block level which collects data including 
number of buildings and type (e.g. residential or commercial or 
institutional), and number of residential buildings accessed 
in each neighbourhood block, (ii) an enumeration form at the 
building level which collects data on the number of dwellings 
(e.g. separate apartments) within each building, number of 
households within each dwelling, total number of males and 
females in each household and the numbers of male and female 
eligible study participants (aged 15 years and above and 
between 2 to 4 years of age); (iii) individual-level question-
naire (separate for adults and children) which collects data on 
symptoms, history of tuberculosis and tuberculosis contact, and 
history of smoking and diabetes for adults only; (iv) a CXR 
form (adult only survey) which collects data on whether CXR 
was performed, refused or missed, and if performed, records 
the CAD4TB score; and (v) a specimen collection form for 
sputum sample and an IGRA test, which records whether the 
test was performed, refused or missed. If a specimen is col-
lected the field staff complete the specimen collection form, the 
application automatically generates a unique order form identi-
fier for that sample which then serves as the specimen number. 
The laboratory results of all tests conducted are entered into 
the associated OpenMRS software installed in the laboratory 
using the unique study identifier and specimen number which 
allows linkage of the field and laboratory data within the 
OpenMRS database.
Each field team also keeps a field log which includes a 
neighbourhood block identifier, building, dwelling and 
household identifiers, unique study participant identifier includ-
ing basic demographic information and mobile contact numbers, 
CXR scores, whether a specimen was collected (sputum or 
blood). Due to limited resources a household level socioeco-
nomic questionnaire is not administered; however, a neighbour-
hood block level paper-based questionnaire is completed at the 
community mobilisation stage to gauge the socioeconomic sta-
tus of the neighbourhood. Study staff undergo systematic training 
on how to collect all data including data pertaining to symptom 
screen, CXR and specimen collection before the start of the 
study with refresher training every 4 months.
Once informed verbal consent has been obtained, a unique 
identifier is assigned to each study participant and all study 
participants are given a paper enrolment card with their allo-
cated unique study identifier, which the study participant then 
presents at the x-ray van or any subsequent contact with the 
study team. Sticker labels of each unique study identifier are 
available in the form of a Quick Response (QR) barcode 
(machine-readable optical label) which are applied to the study 
enrolment card to minimise manual data entry of study identi-
fier. All sputum samples collected are also labelled with unique 
study identifier QR barcode.
Data are stored in a data warehouse and downloaded on a daily 
basis. These data are cleaned and validated on a weekly 
basis before being merged into the final database by the data 
management team.
Data confidentiality
Data confidentiality is strictly maintained. A log for each 
neighbourhood block is kept in a paper register which includes 
the names and contact details of study participants linked to 
their study identifier. These logs are kept locked in a cabinet 
in the office which is only accessible to the project manager. 
Questionnaires are identified using the unique identifier. All 
forms use a format that has been used by IRD for the last 
10 years, which have a built-in suitability for ensuring consist-
ent data collection using hand-held mobile devices. Data are 
stored in password-protected files accessible to a limited 
number of designated individuals. Data are secured by daily 
backing up of databases from the server. All research staff have 
Good Clinical Practice training and undergo refresher train-
ing courses in confidentiality and protocols are in place for the 
handling of data within the field team and in the data office.
Efforts to address potential sources of bias
The main potential source of bias is selection bias; however, 
enumeration of all eligible individuals and recording whether 
they were (i) a survey participant, (ii) absent or (iii) refused 
consent to participate allows an assessment for the presence 
of any systematic biases in the sampled population. The flow 
from eligibility through to participation and results will be 
presented in a flowchart as per the WHO Handbook for TB 
prevalence surveys (see Figure 5)15. Biases for participation in 
the child IGRA survey can also be examined for whether those 
that participated are at a higher risk of M. tuberculosis 
infection using household-level data of known tuberculosis 
contact.
Another potential source of bias in the survey is missing data16. 
A prevalence estimate that uses only individuals with complete 
data on pulmonary tuberculosis will be biased except under 
the strong assumption that those with full information are a ran-
dom subset of eligible study population, which is unlikely to 
be the case. Methods that incorporate multiple imputation as 
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Figure 5. Schematic diagram of numbers of adult participants screened for tuberculosis according to the survey protocol.
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part of individual-level analysis are less biased under a weaker 
assumption, and thus imputation will be used to obtain a more 
valid estimate of tuberculosis prevalence and to assess the bias 
of simpler approaches, such as complete case and cluster-level 
analyses. Addressing this source of bias is addressed in the 
section below as part of the statistical analysis.
Statistical methods
Adult pulmonary tuberculosis prevalence survey
Completeness of data and internal consistency of data. Due 
to the interview process in the field all those who have given 
verbal consent have a symptom screen. Data on the number 
of randomly chosen neighbourhood blocks which declined 
participation or where deemed inaccessible by the survey team 
will be presented. A flowchart (see Figure 5) will be completed 
for all neighbourhood blocks included which will provide a 
description of the flow from enumeration through to participa-
tion in the different stages of the survey16. In addition, an overall     
comparison of age and sex distribution between the Karachi 
population as per the 2017 census with the demographic 
distribution of the survey population will be undertaken. 
Estimation of pulmonary tuberculosis prevalence (primary 
outcome). Cluster-level (cluster defined as neighbourhood 
blocks), and individual-level analyses taking into account 
clustering, will be undertaken to estimate the prevalence of 
bacteriologically confirmed pulmonary tuberculosis.
Complete case analysis using cluster-level data
As Korangi district was over-sampled, a weighted analysis will 
be undertaken. For a cluster-level analysis, culture-confirmed 
tuberculosis prevalence among survey participants will be 
calculated separately for each cluster, and the average cluster-
level prevalence will be calculated. An approximate 95% confi-
dence interval will be calculated for the mean prevalence across 
clusters.
Individual-level analyses
Individual-level analyses will be undertaken to enable adjust-
ment for differences between participants and non-participants 
and multiple imputation of missing data (due to non-participation 
or lack of CAD4TB score or laboratory data), while simultane-
ously allowing for clustering in the sampling design16. Three 
analyses, recommended by the WHO Global Task Force on TB 
impact measurement for analysis of tuberculosis prevalence 
surveys, will be undertaken to estimate the overall pulmonary 
TB prevalence15,16. One method does not take into account 
missing data and two methods correct for bias of missing data, 
including for survey non-participants and among participants 
missing data for CAD4TB and Xpert Ultra and/or culture 
results16. The three approaches, all use logistic regression taking 
into account the clustered design, and are described below:
Model 1. Robust standard errors (complete case 
analysis)
This model is restricted to survey participants and does not 
account for variation in the number of individuals per cluster, 
when estimating the point prevalence of pulmonary tuberculosis. 
Equal weight is given to each individual in the sample. It also 
excludes individuals who were eligible for sputum examina-
tion but for whom Xpert Ultra and/or culture results are miss-
ing. This method thus underestimates true prevalence amongst 
participants because data are missing for individuals who were 
eligible for sputum examination, who have a relative higher 
probability of being diagnosed with TB compared to those not 
eligible16.
Model 2. Robust standard errors with missing value 
imputation
This model uses (multiple) missing value imputation for 
individuals: a) without a CAD4TB score (including those 
who did not participate in the survey) and b) for individuals with 
a CAD4TB score ≥65 or tuberculosis symptoms but without 
an Xpert Ultra and/or culture results, in order to include all 
individuals who were eligible for the survey in the analysis. 
Variables to be considered in the imputation models where 
appropriate will include age, sex, symptoms, CAD4TB, Xpert 
Ultra and culture results, whether it is a katchi abaadi, zone and 
cluster. Cluster will only be used in imputation models with 
a common outcome. This model allows for both the clustering in 
the survey design and the uncertainty introduced by imputation 
of missing values when estimating the 95% confidence 
interval for the prevalence of pulmonary tuberculosis.
Model 3. Robust standard errors with missing value 
imputation (for individuals eligible for sputum 
examination), and inverse probability weighting 
(applied to all survey participants)
Missing value imputation will be used for individuals eligible 
for sputum examination (defined as having a CAD4TB score 
≥ 65 and/or tuberculosis symptoms) for whom data on CAD4TB 
score, Xpert Ultra and culture results are not available and 
inverse probability weighting applied to all survey participants. 
Survey participants are defined for this analysis as individuals 
who participated in the survey and were screened with at least 
a symptom screen. Inverse probability weighting is then used 
to correct for differentials in participation in the survey by age, 
sex, and cluster. Through the combination of imputation of miss-
ing data and the use of weights, the analysis aims to represent 
the whole of the survey eligible population (N1), but the weights 
are applied only to individuals who were screened with at least 
symptoms.
Comparisons of results across models will allow an assessment 
of the robustness of the estimates derived using different ana-
lytical approaches and model assumptions. A sensitivity analysis 
using the ‘probable TB case’ definition will also be undertaken.
Child M. tuberculosis infection survey
The annual risk of infection (ARTI) will be estimated from 
the prevalence of M. tuberculosis, which is inferred from the 
number of positive QFT tests divided by the total number of 
QFT tests performed, using the standard R formula:
                               
( )1 aR 1 1 P= − −
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where R is the probability of being infected in any one year, 
P is prevalence of M. tuberculosis infection and a is the mean 
age at which the observed prevalence is estimated6.
All analyses will be performed in Stata version 16 (Stata Cor-
poration, College Station, USA) and R (The R Foundation for 
Statistical Computing, Vienna, Austria).
Ethics and dissemination
The study protocol has been approved by the ethical review com-
mittee of Interactive Research Development (IRD)/The Indus 
Hospital Research Centre in Karachi in Pakistan (IRD refer-
ence number: IRD_IRB_2017_04_002) and the London School 
of Hygiene & Tropical Medicine (LSHTM) Observational/ 
Interventions Research Ethics Committee (LSHTM ethics 
reference number: 12063).
Informed verbal consent is obtained from each household 
head before accessing the household. Verbal informed consent 
is then obtained from each eligible participant aged 15 years 
and above before enrolment into the study and after a thorough 
explanation of the risks and benefits of participating in the 
study. We specifically applied for a waiver with respect to 
obtaining informed verbal consent rather than informed written 
consent when applying for ethical approval from both ethics 
review committees because it would result in non-representative 
sampling in this setting where a large proportion of the popula-
tion are illiterate and are reluctant to provide fingerprints due to 
concerns about personal security. The participant informa-
tion is read to all participants in their preferred language (Urdu, 
Sindhi, and English). Any questions raised by the potential par-
ticipants are answered before participation in the study. The 
voluntary nature of participation in the survey and the option 
to withdraw from the study at any time without affecting par-
ticipant rights and benefits are explained. Consent for minors 
aged 2 to 4 years is sought from a parent or guardian. Radiation 
safety procedures are applied including protection and monitor-
ing of the workers and participants. Pregnant women will not be 
x-rayed but will only have a symptom screen and asked to 
submit sputum samples irrespective of symptom status. To ensure 
maximum participation and minimise discrimination all indi-
viduals with a physical disability who are unable to mobilise to 
the x-ray van will have a symptom screen and asked to submit 
sputum samples irrespective of symptom status. All tuberculo-
sis cases and participants needing care are referred to the nearest 
health facility.
Findings will be presented locally to the appropriate chan-
nels (regional and national meetings of the Provincial and 
National TB programme) and through the continuing profes-
sional development programme (CPD) at the Indus Hospital. 
This will allow Pakistan public health practitioners and pol-
icy makers to incorporate any relevant findings directly into 
health policy if appropriate. International dissemination will be 
through academic publications and presentations at international 
meetings. Results will also be shared with participating 
communities and collaborators.
Data availability
No data are associated with this article.
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